Without question, some of BioInformant’s most popular content has been our exclusive interviews with stem cell executives and key opinion leaders (KOL). Highlighted below are six of our most popular interviews. Enjoy! [Read more…]
Hematopoietic Stem Cells (HSCs)
No Longer Just for Humans — Cord Blood Banking Now Available to Horses Too
VetiCell, LLC, has announced that it is launching a proactive stem cell storage program for animals, in which it will collect stem cells from the umbilical cord of horses or from the reproductive tissues of dogs following spay or neuter.
VetiCell is a sister company to AlphaCord, a human cord blood bank, with the two companies having the same owner and staff.
Currently, there are a couple companies operating in the veterinary stem cell market that collect stem cells through invasive methods (adipose or bone marrow). However, VetiCell’s new model is to collect veterinary stem cells without surgery from the umbilical cord of horses or from reproductive tissues after canine spay and neuter. These methods require no additional invasive surgery to collect an animal’s stem cells.
Since 2006, BioInformant has been tracking the human stem cell banking market. Initially, the market was focused on the storage of umbilical cord blood, although it has expanded over the past ten years to include the storage of other types of stem cells, including those present within cord tissue, dental pulp, adipose tissue, and more.
With hundreds of human cord blood banks now competing worldwide, it will be interesting to see whether any of them add equine cord blood banking to their portfolio of human stem cell storage services.
Why Perinatal Stem Cells Are Gaining Momentum
Recently back from the Perinatal Stem Cell Society Conference in Aspen, CO, I am excited to share new coverage of the stem cell market with you. At this event, experts from around the world shared cutting-edge research about perinatal tissues over the course of three days (March 2-4, 2016).
We also have interviews with stem cell executives released below, including an interview with Dr. Jon Rowley, Founder and CEO of RoosterBio, and Dr. Racheli Ofir, VP of Research & Intellectual Property at Pluristem Therapeutics. Enjoy this exclusive new content!
Rates of Private Cord Blood Storage in the United States and Worldwide
BioInformant was interviewed by Vogue magazine for an article about the U.S. private cord blood storage industry, authored by Lauren Mechling. Vogue is a fashion and lifestyle magazine that is published monthly in 23 different national and regional editions. It has a total circulation of nearly 1.25 million readers and is one of the Top 25 Consumer Magazines in the U.S.
Private Cord Blood Storage | BI Research Data on Vogue
In this article:
- Vogue Magazine’s Interest On Cord Blood Units
- BioInformant’s Quoted Information on Vogue Magazine
- Global Statistics on Private Cord Blood Storage Banks
Vogue Magazine’s Interest On Cord Blood Units
Vogue needed an approximate quantity of how many cord blood units are now stored within private (family) cord blood banks within the United States. The article released by Vogue was titled, “Could Umbilical Cord Blood Banking Save Your Baby’s Life? Inside the Pregnancy Phenomenon.”
BioInformant’s Quoted Information on Vogue Magazine
BioInformant’s contribution to the article was this important statistic: “There are 1.9M units in private US cord banks, according to market research firm BioInformant.”
Global Statistics on Private Cord Blood Storage Banks
While Vogue did not inquire about global statistics, many of our readers and clients are based outside of the United States. As of January 2016, there were approximately 4.3 million units stored in private cord blood storage banks worldwide.
To view the full Vogue article, click here: http://www.vogue.com/13394836/blood-cord-banking-stem-cell-therapy-benefits-and-costs/
To learn more about the cord blood market, including rates of public and private storage, view the “Global Cord Blood Banking Industry Report.”
How many cord blood units worldwide do you think are in private banks right now? Share your thoughts in the comments section.
Up Next: Cord Blood Industry Trends – Clinical Trials, Publications, Patents, and Grants
NIH’s NIAID Initiating Dose Evaluation Studies in Animal Models of Pluristem’s PLX-R18 in the Treatment of Acute Radiation Syndrome
Pluristem Therapeutics marks its first entry into the defense sector with today’s breaking news. NIAID, a part of the U.S. National Institutes of Health (NIH), will initiate studies in large animals to evaluate dosing for Pluristem’s PLX-R18 as a medical countermeasure in the treatment of the hematologic components of Acute Radiation Syndrome (ARS).
To learn more, read the full press issued by Pluristem, included below with permission from Janet Vasquez, Managing Director/Founder of JVPRVY. [Read more…]
- « Previous Page
- 1
- …
- 17
- 18
- 19
- 20
- 21
- …
- 28
- Next Page »